These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1806468

  • 1. Long-term intramuscular administration of thyrotropin-releasing hormone tartrate in patients with cerebrovascular disease: effects on the pituitary-thyroid axis.
    Monzani F, Pucci E, Fierabracci P, Nebbiai G, Coli A, Caraccio N, De Negri F, Franchi F, Baschieri L.
    Horm Res; 1991; 35(3-4):146-50. PubMed ID: 1806468
    [Abstract] [Full Text] [Related]

  • 2. Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration.
    Merola B, Colao A, Di Renzo G, Filla A, Campanella G, Lombardi G.
    Horm Res; 1992; 38(3-4):160-3. PubMed ID: 1306848
    [Abstract] [Full Text] [Related]

  • 3. [The hypothalamic-Pituitary thyroid axis: studies on the regulatory role of thyrotropin releasing hormone (TRH) (author's transl)].
    Hirooka Y.
    Nihon Naibunpi Gakkai Zasshi; 1976 Sep 20; 52(9):908-25. PubMed ID: 828584
    [Abstract] [Full Text] [Related]

  • 4. Sequential changes in the pituitary thyroid axis after chronic TRH administration: effects on euthyroid and thyroxine treated female rats.
    Iglesias R, Llobera M, Montoya E.
    Acta Endocrinol (Copenh); 1985 Jun 20; 109(2):237-42. PubMed ID: 3925674
    [Abstract] [Full Text] [Related]

  • 5. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM, Taft JA, Reichlin S, Munsat TL.
    J Clin Endocrinol Metab; 1986 Oct 20; 63(4):808-14. PubMed ID: 3091628
    [Abstract] [Full Text] [Related]

  • 6. [Changes in blood levels of the pituitary-thyroid axis observed during therapy with protirelin ++ in hospitalized euthyroid patients with cerebrovascular disease].
    Custro N, Scafidi V, Costanzo G, Corsello FP.
    Minerva Med; 1991 Oct 20; 82(7-8):453-7. PubMed ID: 1922889
    [Abstract] [Full Text] [Related]

  • 7. Effects of three-day oral cholecystography on serum iodothyronines and TSH concentrations: comparison of the effects among some cholecystographic agents and the effects of iopanoic acid on the pituitary-thyroid axis.
    Suzuki H, Kadena N, Takeuchi K, Nakagawa S.
    Acta Endocrinol (Copenh); 1979 Nov 20; 92(3):477-88. PubMed ID: 517049
    [Abstract] [Full Text] [Related]

  • 8. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG, Hershman JM, Chopra IJ, Levine GA, Pekary E, Geffner DL, Chua Teco GN.
    J Clin Endocrinol Metab; 1975 Jul 20; 41(1):70-80. PubMed ID: 807596
    [Abstract] [Full Text] [Related]

  • 9. Alteration by prolonged oral administration of a thyrotropin-releasing hormone analog, TA-0910, of the pituitary-thyroid axis in subjects with brain stroke.
    Miyashita K, Murakami M, Satoh T, Monden T, Yamada M, Iriuchijima T, Kazihara A, Mori M.
    Intern Med; 1993 Sep 20; 32(9):681-5. PubMed ID: 8142670
    [Abstract] [Full Text] [Related]

  • 10. Thyroid-stimulating hormone (tsh), triiodothyronine (t3) and thyroxine (t4) response to intravenous and oral stimulation with synthetic thyrotropin-releasing hormone (trh) in young healthy adults.
    Vogt P, Girard J, Staub JJ.
    Klin Wochenschr; 1978 Jan 01; 56(1):31-5. PubMed ID: 415173
    [Abstract] [Full Text] [Related]

  • 11. The use of intramuscularly administered methyl-TRH to evaluate the pituitary-thyroid axis.
    Levine GA, Sowers JR, Hershman JM.
    Horm Metab Res; 1978 May 01; 10(3):233-6. PubMed ID: 97198
    [Abstract] [Full Text] [Related]

  • 12. Effect of N3im-methyl-thyrotropin releasing hormone on the human pituitary-thyroid axis.
    Sowers JR, Hershman JM, Pekary AE, Nair MG, Baugh CM.
    J Clin Endocrinol Metab; 1976 Oct 01; 43(4):741-8. PubMed ID: 824296
    [Abstract] [Full Text] [Related]

  • 13. Pituitary and peripheral thyroid hormone responses to thyrotropin-releasing hormone during sustained sleep deprivation in freely moving rats.
    Everson CA, Reed HL.
    Endocrinology; 1995 Apr 01; 136(4):1426-34. PubMed ID: 7895653
    [Abstract] [Full Text] [Related]

  • 14. Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin-releasing hormone (TRH).
    Rabello MM, Snyder PJ, Utiger RD.
    J Clin Endocrinol Metab; 1974 Sep 01; 39(3):571-8. PubMed ID: 4213076
    [No Abstract] [Full Text] [Related]

  • 15. Pituitary unresponsiveness to thyrotropin-releasing hormone in thyrotoxic patients during chronic anti-thyroid drug therapy and in rats previously treated with excess thyroid hormone.
    Harada A, Kojima A, Tsukui T, Onaya T, Yamada T, Ikejiri K, Yukimura Y.
    J Clin Endocrinol Metab; 1975 Jun 01; 40(6):942-8. PubMed ID: 805794
    [Abstract] [Full Text] [Related]

  • 16. Effect of iodine upon the TRH induced release of TSH in euthyroid, hypothyroid and hyperthyroid individuals.
    Waldhäusl W, Haydl H.
    Horm Metab Res; 1976 Jul 01; 8(4):286-91. PubMed ID: 821840
    [Abstract] [Full Text] [Related]

  • 17. [Tolerance of long-term protirelin tartrate treatment].
    Caraccio N, Monzani F, Casolaro A, Pucci E, Luisi M, Franchi F.
    Recenti Prog Med; 1995 Jun 01; 86(6):226-30. PubMed ID: 7624581
    [Abstract] [Full Text] [Related]

  • 18. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1973 Sep 01; 52(9):2305-12. PubMed ID: 4199417
    [Abstract] [Full Text] [Related]

  • 19. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule.
    Ridgway EC, Weintraub BD, Cevallos JL, Rack MC, Maloof F.
    J Clin Invest; 1973 Nov 01; 52(11):2783-92. PubMed ID: 4201265
    [Abstract] [Full Text] [Related]

  • 20. Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella.
    Cannavò S, Curtò L, Venturino M, Squadrito S, Almoto B, Narbone MC, Rao R, Trimarchi F.
    J Endocrinol Invest; 2002 Mar 01; 25(3):236-9. PubMed ID: 11936465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.